One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like New class of insecticide offers yearlong protection against mosquito-borne diseases August 26, 2025 New RNA therapy offers hope for mental health September 6, 2024 Cardiologists highlight overlooked heart risks across women’s lives February 3, 2026